Anti-angiogenic drugs, used for cancer treatment, target blood-vessel formation in tumours. Two studies commented here show that such drugs can reduce the efficiency of other anticancer agents and increase the aggressiveness of tumours
Resistance to anti-vascular endothelial growth factor (VEGF) molecules causes lack of response and d...
Angiogenesis is critical for oxygen and nutrient delivery to proliferating tumor cells. Therefore, a...
According to WHO report, more than 8 million people died globally from cancer only in year 2012 (lat...
Clinical trials using anti-vascular endothelial growth factor /(VEGF) molecules induce a modest impr...
Vascular endothelial growth factor (VEGF) has been identified as the most potent cytokine involved i...
Tumours require a vascular supply to grow and can achieve this via the expression of pro-angiogenic ...
Andrew Eichholz, Shairoz Merchant, Andrew M GayaDepartment of Clinical Oncology, Guy’s and...
Background: Angiogenesis is the formation of new vascular networks from preexisting ones through the...
Despite advances in surgery, radiation therapy, and chemotherapy, patients with cancer have a poor p...
Contains fulltext : 51115.pdf (publisher's version ) (Closed access)It has long be...
Deregulated angiogenesis has been identified as a key contributor in a number of pathological condit...
Thesis (Ph. D.)--Harvard-MIT Division of Health Sciences and Technology, 2005.Includes bibliographic...
Vascular endothelial growth factor (VEGF) pathway targeting agents have been combined with other ant...
Tumor angiogenesis defines tumor growth as it is dependent on generation of new blood vessels. Over ...
The mechanisms of tumor growth and progression involve the activation of different processes such as...
Resistance to anti-vascular endothelial growth factor (VEGF) molecules causes lack of response and d...
Angiogenesis is critical for oxygen and nutrient delivery to proliferating tumor cells. Therefore, a...
According to WHO report, more than 8 million people died globally from cancer only in year 2012 (lat...
Clinical trials using anti-vascular endothelial growth factor /(VEGF) molecules induce a modest impr...
Vascular endothelial growth factor (VEGF) has been identified as the most potent cytokine involved i...
Tumours require a vascular supply to grow and can achieve this via the expression of pro-angiogenic ...
Andrew Eichholz, Shairoz Merchant, Andrew M GayaDepartment of Clinical Oncology, Guy’s and...
Background: Angiogenesis is the formation of new vascular networks from preexisting ones through the...
Despite advances in surgery, radiation therapy, and chemotherapy, patients with cancer have a poor p...
Contains fulltext : 51115.pdf (publisher's version ) (Closed access)It has long be...
Deregulated angiogenesis has been identified as a key contributor in a number of pathological condit...
Thesis (Ph. D.)--Harvard-MIT Division of Health Sciences and Technology, 2005.Includes bibliographic...
Vascular endothelial growth factor (VEGF) pathway targeting agents have been combined with other ant...
Tumor angiogenesis defines tumor growth as it is dependent on generation of new blood vessels. Over ...
The mechanisms of tumor growth and progression involve the activation of different processes such as...
Resistance to anti-vascular endothelial growth factor (VEGF) molecules causes lack of response and d...
Angiogenesis is critical for oxygen and nutrient delivery to proliferating tumor cells. Therefore, a...
According to WHO report, more than 8 million people died globally from cancer only in year 2012 (lat...
DOI
Add to ORKG